Loading clinical trials...
Loading clinical trials...
Evaluation of the frequency of symptomatic and incidental detection of renal carcinoma at different stages depending on the imaging modality used
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Charles University, Czech Republic
Collaborators
NCT07117227 · Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), and more
NCT05665361 · Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc)
NCT07485114 · Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, and more
NCT06349668 · Other Specified Disorders of Kidney and Ureter, Benign Neoplasm of Ureter, and more
NCT06318871 · Renal Carcinoma, Renal Cell Carcinoma, and more
University Hospital Královské Vinohrady
Prague
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions